Prevalence and profile of people with co-occurring mental and substance use disorders within a comprehensive mental health system

Canadian Journal of Psychiatry

Volumn 53, Issue 12, 2008, Pages 810-821

  Rush, Brian ^a,b   Koegl, Christopher J ^c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Addictions; Co occurring disorders; Colorado client assessment record; Comorbidity; Mental health; Mental health system research; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTISOCIAL BEHAVIOR; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEALTH PROGRAM; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH SERVICE; OUTPATIENT CARE; PERSONALITY DISORDER; PREVALENCE; SUBSTANCE ABUSE; SUICIDE ATTEMPT; TERTIARY HEALTH CARE;

EID: 58149215902     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370805301207     Document Type: Article

References (71)

1. Health Canada. Best practices: concurrent mental health and substance use disorders. Ottawa (ON): Health Canada; 2001.
2. Drake RE, Brunette MF. Complications of severe mental illness related to alcohol and drug use disorders. In: Galanter M, editor. Recent developments in alcoholism: the consequences of alcoholism. New York (NY): Plenum Press; 1998. p 285-299.
3. RachBeisel J, Scott J, Dixon L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv. 1999;50(11):1427-1434.
4. Osher FC, Drake RE, Noordsy DL, et al. Correlates and outcomes of alcohol use disorders among rural outpatients with schizophrenia. J Clin Psychiatry. 1994;55(3):109-113.
5. Schmidt L. A profile of problem drinkers in public mental health services. Hosp Community Psychiatry. 1992;43(3);245-250.
6. Todd J, Green G, Harrison M, et al. Social exclusion in clients with comorbid mental health and substance misuse problems. Soc Psychiatry Psychiatr Epidemiol. 2004;39:581-587.
7. Barry KL, Fleming MF, Greenley JR, et al. Characteristics of persons with severe mental illness and substance abuse in rural areas. Psychiatr Serv. 1996;47(1):88-90.
8. Mueser KT, Rosenberg SD, Drake RE, et al. Antisocial personality disorders and substance abuse in schizophrenia and major affective disorders. J Stud Alcohol. 1999;60:278-284.
9. Angst JR, Sellaro R, Merikangas KR. Multimorbidity of psychiatric disorders as an indicator of clinical severity. Eur Arch Psychiatry Clin Neurosci. 2002;252:147-154.
10. McDermott WJ, Mattia J, Zimmerman M. Comorbidity burden and its impact on psychosocial morbidity in depressed outpatients. J Affect Disord. 2001;65:289-295.
11. Reiger DA, Farmer ME, Rae DS. Co-morbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) study. JAMA. 1990;264;2511-2518.
12. Kessler RC, Nelson CB, McConagle KA, et al. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996;66:17-61.
13. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627.
14. Grant BF, Stinson FS, Dawson DA, et al. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States. Arch Gen Psychiatry. 2004;61:361-368.
15. Brooner RK, King VL, Kidorf M, et al. Psychiatric and substance use co-morbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54:71-80.
16. Mueser KT, Yarnold PR, Levinson DF, et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull. 1990;16:31-56.
17. Hien D, Zinberg S, Weisman S, et al. Dual diagnosis sub-types in urban substance abuse and mental health clinics. Psychiatr Serv. 1997;48:1058-1063.
18. Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry. 1998;4:1023-1031.
19. Galanter M, Casteneda R, Ferman J. Substance abuse among general psychiatric patients: place of presentation, diagnosis and treatment. Am J Drug Alcohol Abuse. 1988;142:211-235.
20. Myers P, Corty E, Thompson J. Prevalence and patterns of "dual diagnosis" among psychiatric inpatients. Compr Psychiatry. 1994;35(2):267-271.
21. Kamali M, Kelly L, Gervin M, et al. The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatr Scand. 2000;101(6):452-456.
22. Dixon L, Dibietz E, Myers P, et al. Comparison of DSM-III-R diagnoses and a brief interview for substance use among state hospital patients. Hosp Community Psychiatry. 1993;44(8):748-752.
23. Toner BB, Shugar G, Campbell B, et al. Patterns of substance abuse in psychiatric inpatients. Can J Psychiatry. 1991;36:381-383.
24. Lehman AF, Meyers P, Corty E, et al. Prevalence and patterns of "dual diagnosis" among psychiatric inpatients. Compr Psychiatry. 1994;35(2):267-271.
25. Mueser KT, Yarnold PR, Bellack AS. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand. 1992;85:48-55.
26. Milling RN, Faulkner LR, Craig JM. Problems in the recognition and treatment of patients with dual diagnoses. J Subst Abuse Treat. 1994;11(3):267-271.
27. Havassy BE, Alvidrez J, Owen, KK. Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery. Am J Psychiatry. 2004;161(1):139-145.
28. Toner BB, Gillies LA, Prendergast P, et al. Substance use disorders in a sample of Canadian patients with chronic mental illness. Hosp Community Psychiatry. 1992;43:251-254.
29. Ford L, Snowdon LR, Walser EJ. Outpatient mental health and the dual-diagnosis patient: utilization of services and community adjustment. Eval Program Plann. 1991;14:291-298.
30. Eastbrooke S, Krupa T, Horgan S, et al. Substance abuse in a Canadian population of assertive community treatment (ACT) clients: implications for service planning and delivery. Can J Nurs Res. 2003;35(1):44-51.
31. Osher FC, Drake RE, Noordsy DL, et al. Correlates and outcomes of alcohol use disorder among rural outpatients with schizophrenia. J Clin Psychiatry. 1994;55(3):109-113.
32. Duke P, Pantelis C, Barnes T. South Westmister schizophrenia study: alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br J Psychiatry. 1994;164:630-636.
33. Graham Hl, Maslin J, Copello A, et al. Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK. Soc Psychiatry Psychiatr Epidemiol. 2001;36:448-455.
34. Menezes P, Johnson S, Thornicroft G, et al. Drug and alcohol problems among individuals with severe mental illnesses in South London. Br J Psychiatry. 1996;168:612-619.
35. Raskin VD, Miller NS. The epidemiology of the comorbidity of psychiatric and addictive disorders: a critical review. J Addict Dis. 1993;12(3):45-57.
36. Mueser KT, Yarnold PR, Levinson DF, et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull. 1990;16(1):31-56.
37. Siegfried N. A review of comorbidity: major mental illness and problematic substance use. Aust N Z J Psychiatry. 1998;32(5):707-717.
38. Buckley PF. Substance abuse in schizophrenia: a review. J Clin Psychiatry. 1998;59(Suppl 3):26-30.
39. Melartin TK, Rytsala HJ, Leskela US, et al. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J Clin Psychiatry. 2002;63(2):126-134.
40. Virgo N, Bennett G, Higgins D, et al. The prevalence and characteristics of co-occurring serious mental illness (SMI) and substance abuse or dependence in the patients of Adult Mental Health and Addiction Services in eastern Dorset. J Ment Health. 2001;10(2):175-188.
41. Skinner W. Treating concurrent disorders: a guide for counselors. Toronto (ON): Centre for Addiction and Mental Health; 2005.
42. Center for Substance Abuse Treatment: Substance Abuse Treatment for Persons With Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series 42. DHHS Publication No (SMA) 05-3922. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2005.
43. Koegl CJ, Durbin J, Goering P. Mental health services in Ontario: how well is the province meeting the needs of persons with serious mental illness? Toronto (ON): Centre for Addiction and Mental Health; 2004.
44. Ellis RJ, Wackwitz JH, Foster M. Uses of an empirically derived client typology based on level of functioning: twelve years of the CCAR. J Ment Health Adm. 1991;18:88-100.
45. Ellis R, Wilson N, Foster F. Statewide treatment outcome assessment in Colorado: the Colorado Client Assessment Record (CCAR). Comm Ment Health J. 1984;20:72-89.
46. Coffman JM. Assessing the validity of the Colorado Client Assessment Record for measurement of mental health status and outcomes. Poster presented at the 132nd Annual Meeting of the American Public Health Association; 2004 November; Washington (DC).
47. Schwartz RC. Reliability and validity of the functional assessment rating scale. Psychol Rep. 1999;84:389-391.
48. Durbin J, Cochrane J, Goering P, et al. Needs-based planning: an evaluation of a level-of-care planning model. J Behav Health Serv Res. 2001;28:68-80.
49. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): APA; 1994.
50. Ananth J, Vandewater S, Kamal M, et al. Missed diagnosis of substance abuse in psychiatric patients. Hosp Comm Psychiatry. 1989;40(3):297-301.
51. Barnaby B, Drummond C, McCloud A, et al. Substance misuse in psychiatric inpatients: comparison of a screening questionnaire survey with case notes. BMJ. 2003;327:783-784.
52. Cohen J. Statistical power analyses for the behavioral sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum; 1988.
53. Centre for Addiction and Mental Health. Making a difference: Ontario's Community Mental Health Evaluation Initiative [Internet]. Toronto (ON): CAMH; 2004 [cited October 23, 2007]. Available from: http://www.ontario.cmha.ca/cmhei/ images/report/Making_a_Difference.pdf.
54. Drake RE, Wallach MN. Substance abuse among the chronically mentally ill. Hosp Comm Psychiatry. 1989;40(3):1041-1046.
55. Rush BR, Urbanoski K, Bassani D, et al. Prevalence of co-occurring substance use and other mental disorders in the Canadian population. Can J Psychiatry. 2008;53(12):800-809.
56. Kranzler HR, Kadden RM, Babor TF, et al. Longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders. J Nerv Ment Dis. 1994;182:277-283.
57. Substance Abuse and Mental Health Services Administration. Report to Congress on the prevention and treatment of co-occurring substance abuse disorders and mental disorders. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2002.
58. Toneatto T. Screening and assessment of co-occurring disorders: towards a phenomenological approach. Int J Ment Health Addiction. 2008;6(1):37-44.
59. Mueser KT, Noordsy DL, Drake RE, et al. Integrated treatment for dual diagnosis. New York (NY): Guilford Press; 2003.
60. Steadman HJ, Mulvey EP, Monahan J, et al. Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighbourhoods. Arch Gen Psychiatry. 1998;55:393-401.
61. Rush BR, Scott CK, Dennis ML, et al. The interaction of co-occurring psychiatric problems and recovery management checkups. Eval Rev. 2008;32(1):7-38.
62. Chan Y-F, Dennis ML, Funk RR. Prevalence and comorbidity co-occurrence of major internalizing and externalizing disorders among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat. 2008;34(1):14-24.
63. Abram KM, Teplin LA. Co-occurring disorders among mentally ill jail detainees. Am Psychol. 1991;46:1036-1045.
64. Miller RD. Outpatient civil commitment of the mentally ill: an overview and an update. Behav Sci Law. 2005;6(1):99-118.
65. Steadman HJ, Naples M. Assessing the effectiveness of jail diversion programs for persons with serious mental illness and co-occurring substance use disorders. Behav Sci Law. 2005;23:163-170.
66. Morrissey J, Meyer P. Extending ACT to criminal justice settings: applications, evidence, and options [Internet]. Discussion paper presented at the Evidence-based Practice for Justice Involved Individuals: Assertive Community Treatment Expert Panel Meeting sponsored by the National GAINS Center for Systemic Change for Justice-Involved Persons through the Center for Mental Health Services, SAMHSA. Rockville (MA); 2005 [cited Oct. 2, 2007]. Available from: http://gainscenter.samhsa.gov/text/ebp/Papers/ExtendingACTPaper.asp.
67. McCoy ML, Roberts DL, Hanrahan P, et al. Jail linkage assertive community treatment services for individuals with mental illnesses. Psychiatr Rehabil J. 2004;27(3):243-250.
68. Weisman RL, Lamberti JS, Price N. Integrating criminal justice, community health care, and support services for adults with severe mental disorders. Psychiatr Q. 2004;75(1):71-85.
69. Hser Y-I, Longshore D, Anglin MD. The life course perspective on drug use: a conceptual framework for understanding drug use trajectory and its management. Eval Rev. 2007;31(6):515-547.
70. Hoff R, Rosenheck RA. Long-term patterns of service use and cost among patients with both psychiatric and substance abuse disorders. Med Care. 1998;36:835-843.
71. Dickey B, Azeni H. Persons with dual diagnosis of substance abuse and major mental illness: their excess costs of psychiatric care. Am J Public Health. 1996;86:973-977.